Logos Biosystems, a leading developer of various cellular imaging instruments for life science research, announced that it has entered into an agreement with Stanford University in order to access to the intellectual properties for the CLARITY technology, a novel tissue clearing method that allows researchers to obtain optically transparent and macromolecular-permeable brain tissue. This innovative technology provides big potential for breakthroughs in brain mapping research. This licensing agreement is the first step for Logos Biosystems to create the world’s first commercial instrument for the CLARITY technology.
CLARITY, created by Professor Karl Deisseroth and his team at Stanford, is a breakthrough technology published in Nature on April 10, 2013, that makes mouse brain transparent by using hydrogel and SDS to remove neural lipids that normally block the passage of light (Chung K et al., 2013).
“Logos Biosystems has been providing innovative research instruments to biomedical and life science researchers and now is committed to offer the world’s first commercial instrument for CLARITY, which will contribute to brain mapping-related projects around the world,” commented Dr. Neon Jung, CEO of Logos Biosystems.